Shares of K2M Group Holdings, Inc. (NASDAQ:KTWO) have been assigned a consensus rating of “Buy” from the eleven analysts that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $26.67.

KTWO has been the subject of a number of research analyst reports. Oppenheimer Holdings, Inc. set a $29.00 price target on K2M Group Holdings and gave the company a “buy” rating in a report on Wednesday, August 2nd. JMP Securities reaffirmed an “outperform” rating and issued a $30.00 price target (up from $27.00) on shares of K2M Group Holdings in a report on Wednesday, June 28th. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $26.00 price target on shares of K2M Group Holdings in a report on Thursday, July 20th. Needham & Company LLC reaffirmed a “buy” rating on shares of K2M Group Holdings in a report on Wednesday, August 2nd. Finally, BidaskClub raised K2M Group Holdings from a “hold” rating to a “buy” rating in a report on Wednesday, July 19th.

In other news, insider John Philip Md Kostuik sold 50,000 shares of the stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $22.70, for a total value of $1,135,000.00. Following the completion of the sale, the insider now directly owns 199,107 shares of the company’s stock, valued at $4,519,728.90. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Gregory S. Cole sold 42,947 shares of the stock in a transaction that occurred on Friday, June 16th. The shares were sold at an average price of $22.80, for a total value of $979,191.60. Following the completion of the sale, the chief financial officer now directly owns 87,425 shares of the company’s stock, valued at $1,993,290. The disclosure for this sale can be found here. Insiders sold 93,903 shares of company stock valued at $2,137,451 over the last three months. Corporate insiders own 5.80% of the company’s stock.

Large investors have recently bought and sold shares of the stock. TimesSquare Capital Management LLC increased its stake in K2M Group Holdings by 31.5% in the second quarter. TimesSquare Capital Management LLC now owns 2,888,020 shares of the medical device company’s stock valued at $70,352,000 after buying an additional 691,000 shares during the last quarter. Wellington Management Group LLP increased its stake in shares of K2M Group Holdings by 10.4% in the first quarter. Wellington Management Group LLP now owns 1,875,913 shares of the medical device company’s stock valued at $38,475,000 after buying an additional 175,998 shares in the last quarter. Schroder Investment Management Group increased its stake in shares of K2M Group Holdings by 1.6% in the second quarter. Schroder Investment Management Group now owns 1,560,340 shares of the medical device company’s stock valued at $37,401,000 after buying an additional 24,671 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of K2M Group Holdings by 12.4% in the second quarter. Vanguard Group Inc. now owns 1,550,592 shares of the medical device company’s stock valued at $37,772,000 after buying an additional 171,502 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in shares of K2M Group Holdings by 54.3% in the first quarter. JPMorgan Chase & Co. now owns 1,409,360 shares of the medical device company’s stock valued at $28,906,000 after buying an additional 495,749 shares in the last quarter. 96.79% of the stock is owned by institutional investors and hedge funds.

K2M Group Holdings (KTWO) traded up 1.97% during trading on Friday, reaching $23.77. 257,042 shares of the company’s stock were exchanged. K2M Group Holdings has a 52 week low of $15.45 and a 52 week high of $25.99. The stock has a 50-day moving average of $24.01 and a 200-day moving average of $21.93. The stock’s market capitalization is $1.03 billion.

K2M Group Holdings (NASDAQ:KTWO) last announced its quarterly earnings results on Tuesday, August 1st. The medical device company reported ($0.21) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.22) by $0.01. The firm had revenue of $65.70 million during the quarter, compared to the consensus estimate of $66.26 million. K2M Group Holdings had a negative return on equity of 15.45% and a negative net margin of 16.21%. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.27) earnings per share. On average, equities research analysts anticipate that K2M Group Holdings will post ($0.78) EPS for the current year.

ILLEGAL ACTIVITY WARNING: “K2M Group Holdings, Inc. (KTWO) Given Average Rating of “Buy” by Brokerages” was first published by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://www.watchlistnews.com/k2m-group-holdings-inc-ktwo-given-average-rating-of-buy-by-brokerages/1478962.html.

K2M Group Holdings Company Profile

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine and minimally invasive technologies and techniques. The Company’s solutions are focused on achieving three-dimensional Total Body Balance. Its spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor.

Analyst Recommendations for K2M Group Holdings (NASDAQ:KTWO)

Receive News & Ratings for K2M Group Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for K2M Group Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.